Home › BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns with Sunshine Act Implementation
 

Keywords :   


BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns with Sunshine Act Implementation

2014-09-22 06:00:00| Industrial Newsroom - All News for Today

BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO John Castellani in letter to CMS Administrator Marilyn Tavenner highlighting ongoing concerns about potential lack of necessary context around Sunshine data release. Physician Payments Sunshine Act, section 6002 of Affordable Care Act of 2010, will provide transparency in industry collaboration with teaching hospitals, physicians; and report physician ownership and investment ...This story is related to the following:Trade Associations

Tags: act letter concerns implementation

Category:Industrial Goods and Services

Latest from this category

All news
01.10Boosting Membership Value
Industrial Goods and Services »
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »